Quantcast

Latest Isis Stories

2014-05-06 08:35:15

-Conference Call Webcast Tuesday, May 6, 11:30 a.m. ET at www.isispharm.com CARLSBAD, Calif., May 6, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today reported a pro forma net operating loss (NOL) of $22.6 million for the three months ended March 31, 2014 compared to pro forma operating income of $4.5 million for the same period in 2013. Isis' first quarter 2014 pro forma NOL was higher than the same period last year primarily due to variations in the timing of milestone...

2014-05-02 08:24:15

Significant reductions of more than 1,500 mg/dL in triglycerides observed CARLSBAD, Calif., May 2, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced the final data from its Phase 2 study of ISIS-APOCIII(Rx) as a monotherapy in patients with familial chylomicronemia syndrome, or FCS. In this open-label study, three patients with FCS treated with ISIS-APOCIII(Rx) achieved substantial reductions in triglycerides with all three patients achieving a triglyceride...

2014-05-01 23:13:00

Public Sex, Private Lives, an intimate documentary portrait of adult performers Lorelei Lee, Princess Donna, and Isis Love, will be released online May 14th via Vimeo on Demand. San Francisco, CA (PRWEB) May 01, 2014 Public Sex, Private Lives, an intimate documentary portrait of adult performers Lorelei Lee, Princess Donna, and Isis Love, will be released online May 14th via Vimeo on Demand. The film will be available for both rental and purchase May 14th at vimeo.com/ondemand/pspl and is...

2014-05-01 16:31:42

CARLSBAD, Calif., May 1, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Deutsche Bank 39(th) Annual Health Care Conference on Wednesday, May 7, 2014 at 12:50 p.m. ET in Boston, MA. http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO A live webcast of the presentation will be available on the "Investors & Media" section of the Company's website,...

2014-05-01 08:34:54

- 69 percent reduction in triglycerides achieved CARLSBAD, Calif., May 1, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced the final results from its Phase 2 study of ISIS-APOCIII(Rx) in patients with high triglycerides and type 2 diabetes. In this study, patients treated with ISIS-APOCIII(Rx) achieved statistically significant average mean percent reduction from baseline of 88 percent (p=0.02) in apolipoprotein C-III (apoC-III) and 69 percent (p=0.02) in...

2014-04-30 08:32:02

CARLSBAD, Calif., April 30, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that the strategic alliance between Isis and Biogen Idec (NASDAQ:BIIB) has been honored with the Alliance 2014 Breakthrough Award. The award, sponsored by Thomson Reuters Recap, was presented at the Allicense 2014 Conference in San Francisco on April 29, 2014. http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO "We are grateful for the award and recognition of our...

2014-04-30 08:32:01

CARLSBAD, Calif., April 30, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announces the following webcast: What: Isis Pharmaceuticals' First Quarter 2014 Financial Results and Highlights Conference Call When: Tuesday, May 6 at 11:30 a.m. ET /8:30 a.m. PT Where: www.isispharm.com How: Live on...

2014-04-29 12:34:49

Results presented at the American Academy of Neurology meeting CARLSBAD, Calif., April 29, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today provided an update on both of its ongoing open-label Phase 2 clinical studies of ISIS-SMN(Rx) in infants and children with spinal muscular atrophy (SMA) at the 66(th) American Academy of Neurology (AAN) meeting in Philadelphia, PA. http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO Results from Phase 2 study in infants with SMA...

2014-04-22 08:32:24

- Event and webcast scheduled on Tuesday, April 29 at 6:00 p.m. Eastern Time CARLSBAD, Calif., April 22, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it will host an investor event and a live webcast on Tuesday, April 29, 2014 at 6:00 p.m. Eastern Time to discuss the ISIS-SMN(Rx) data presented at the 2014 American Academy of Neurology Annual Meeting. http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO Interested parties may register to...

2014-04-07 23:24:16

EditShare workflow supports servers and applications from Adobe, Avid, Broadcast Pix and NewTek – showcased at NAB 2014 on booth SL5709. Boston, MA (PRWEB) April 07, 2014 EditShare®, the technology leader in shared media storage and end-to-end tapeless workflow solutions, is qualifying a number of new third-party integrations for use across the EditShare workflow. New and enhanced integrations include Adobe® Anywhere®, Avid® ISIS® storage systems, Broadcast Pix...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.